Phoenix Group Holdings PLC(PHNX)
GBX --+0.00%
Reward65Moderate
Risk48Moderate
📊75%Data
Thin -3% profit margin · 7.1% dividend yield · Revenue down 31% YoY
PHNX
+0.0 · +0.00%
GBX · LSE
Phoenix Group Holdings PLC | Financial Services
Dividend King
Market Cap:7.68Bn
ℹ️
Reward Rating
65
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
48
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: 758p.

What is Phoenix Group Holdings PLC?

Standard Life plc operates in the long-term savings and retirement business in Europe.

PHNX · Verdict

Solid reward · moderate risk

PHNX stands out on valuation and growth, but watch the profitability signal.

Based on 88% data coverage

PHNX · Verdict

What’s working & what to watch

Strengths 2

  • Valuation93/100

    P/E 10.7× · PEG -1.41

  • Growth75/100

    Rev +45.2% CAGR · earnings +9.2%

Watchouts 2

  • Profitability44/100

    -5% net margin · -25% ROE

  • Cash flow45/100

    16% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Phoenix Group Holdings PLC?

Standard Life plc operates in the long-term savings and retirement business in Europe. It operates through Retirement Solutions, Pensions & Savings, With-Profits, SunLife & Protection, and Europe & Other segments. The company is listed on the LSE in UK, operating in the Financial Services sector, with a market capitalisation of 7.68B.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (65)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorFinancial Services
Market Cap7.68B
P/E RatioN/A
Dividend Yield7.14%
52 Week High774.5
52 Week Low460.2944
Last AnnualDecember
IPO Date2/6/2008
IncorporatedUK
Shares Outstanding1B
No. of Employees6,980
IndustryInsurance - Life
ExchangeLSE
Beta0.847
CurrencyGBX

Chart Tools

Sign in to overlay your portfolio on the chart.

Sign in
Uses ISF.L (iShares FTSE 100 ETF)
Indicators

Performance Metrics

Historical returns

Annual Returns

Calendar year performance

Insufficient price history.
Fundamentals
Fundamentals Insights
Educational tool only. Not financial advice.

Business Snapshot

  • Revenue TrendDecelerating
  • Profitability TrendImproving
  • Balance Sheet StrengthModerate
  • Cash GenerationStrong

Risk Flags

Structural indicators detected (5):
Balance Sheet
  • Tangible equity is negative (equity less goodwill and intangibles).
  • Interest coverage is -4.01x (below 3.0x).
  • Net debt growth is outpacing EBITDA growth by 36.7pp (CAGR spread).
  • Goodwill and intangibles are 110.3% of equity.
  • Net debt has shown elevated year-over-year volatility.

What Changed This Year

Compared to 2023:
  • Operating Income↑ 10513.0%
  • Net Income↓ 710.9%
  • Free Cash Flow↑ 487.4%
  • EBITDA↓ 385.2%

Income Statement

CAGR: N/A
CAGR: N/A
CAGR: N/A

Balance Sheet

CAGR: N/A
CAGR: N/A
CAGR: N/A
CAGR: N/A

Cash Flow

CAGR: N/A
CAGR: N/A
CAGR: N/A

Key Ratios

Net Margin
-5.09%
Net Income / Revenue
Operating Margin
91.21%
Operating Income / Revenue
ROE
-63.85%
Net Income / Equity
Debt-to-Equity
-3.43x
Net Debt / Equity
FCF Yield
43.52%
FCF / Market Cap
Key Takeaway

Strong insider commitment backed by substantial institutional support indicates high conviction.

15.1% Insider 52.8% Institutional 32.1% Float
68%
Total Owned
Insider
Institutional
Public Float
15.1%
Insider

Insider Ownership

Bullish

Insiders own 15.1%, which suggests meaningful management commitment to the business.

52.8%
Institutional

Institutional Ownership

Moderate

Institutions own 52.8%, which suggests a balanced ownership mix.

32.1%
Public

Public Float

Low

Public float is 32.1%, which points to a fairly balanced ownership structure.

Reward Rating Breakdown

Our Reward Rating provides a model-based reward profile for PHNX using 5 weighted factors. Each factor is scored 0-100 and combined using the weights shown below.

Overall Reward Rating
65
Moderate REWARD
Data Coverage: 75%

📈 Growth

Weight: 40%
75/100

Growth measures the company's ability to expand its business over time through revenue, earnings, and cash flow generation.

Historical (60%)
Revenue CAGR (3yr)
45.2%
Very Good
Net Income CAGR (3yr)
9.2%
Neutral
FCF CAGR (3yr)
Neutral
Forward Estimates (40%)
Rev Est Growth (NTM)
3.2%
Neutral
EPS Est Growth (NTM)
34.0%
Very Good
Analyst Target Upside
Neutral
🤖Model Commentary

PHNX scored 75/100 for growth, blending a 3-year historical track record (60%) with analyst forward estimates (40%). Historical revenue CAGR of 45.2% is above model thresholds. Forward: analysts forecast 3.2% revenue growth next year, EPS expected to grow 34.0%. Overall, growth metrics are strong relative to this model's thresholds. Forecasts and analyst targets are estimates and may be inaccurate.

🚀 Momentum

Weight: 25%
50/100

Momentum is assessed relative to the FTSE 100 benchmark where available. This provides context for recent price movement across different market conditions.

12M vs Benchmark 30%
Absolute return
No Benchmark
6M vs Benchmark 25%
Absolute return
No Benchmark
3M Return 20%
Neutral
Consistency 15%
3m vs 1Y/4 normalised
No Data
Volume Trend 10%
30d vs 90d avg volume
Neutral
🤖Model Commentary

Insufficient price history to assess momentum. Score defaulted to neutral (50).

💰 Profitability

Weight: 20%
44/100

Profitability examines both the current margin level and margin expansion trends. High and expanding margins indicate pricing power and operational efficiency.

Gross Margin 25%
100.0%
Sector avg 45%
Higher Relative
Net Margin 20%
-5.1%
Sector avg 10%
Loss Making
FCF Conversion 20%
>200%
FCF / Net Income
Very Good
EBIT Growth (3yr) 15%
Neutral
ROE (TTM) 10%
-25.4%
Very Bad
ROA (TTM) 10%
-0.0%
Very Bad
🤖Model Commentary

PHNX scores 44/100 for profitability, assessed sector-relative on margins and via absolute thresholds for capital efficiency. Gross margin of 100.0% is 122% above the sector average of 45% — indicating margins are materially above peers. The company is currently loss-making with a net margin of -5.1%. FCF conversion of >200% indicates reported profits are strongly supported by cash flow. Overall, profitability appears moderate and may require improvement for stronger resilience. Profitability trends can change and should be reviewed alongside balance-sheet risk.

💎 Valuation

Weight: 15%
93/100

Valuation is scored sector-relative — each metric is compared against the typical multiple for this industry, so a high P/E in Healthcare is judged differently to a high P/E in Energy. PEG and Price/FCF use absolute thresholds.

PEG Ratio 25%
-1.41
No Data
EV/EBITDA 25%
0.0x
Sector avg 12x
Higher Relative Value
Fwd P/E 20%
10.7x
Sector avg 18x
Higher Relative Value
Price/FCF 20%
2.3x
Higher Relative Value
EV/Sales 10%
0.1x
Sector avg 2x
Higher Relative Value
🤖Model Commentary

PHNX received a valuation score of 93/100 using sector-relative scoring. Its Forward P/E of 10.7x is 40% below the sector average of 18x. EV/EBITDA of 0.0x sits 100% below the sector norm of 12x. Price/FCF of 2.3x is low on this model's cash-yield lens. Overall, valuation multiples are lower than selected sector peers on this model. Valuation metrics are not forecasts of future returns.

⚠️

Educational Tool Only

The reward rating and analysis shown above are based on historical financial data and quantitative metrics, provided for informational and educational purposes only. This is not financial advice and should not be interpreted as a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Always conduct your own research or consult a qualified financial adviser before making investment decisions.

Risk Rating Breakdown

Our Risk Rating provides a model-based risk profile for PHNX using 4 weighted factors. Each factor is scored 0-100 (higher = riskier), then combined using the weights shown below.

Overall Risk Rating
48
Moderate RISK
Data Coverage: 100%

⚖️ Financial Solvency

Weight: 35%
43/100

Financial Solvency measures the company's ability to service and repay its debt obligations. Five sub-metrics are weighted to produce the composite score.

Interest Coverage (25%)
-4.0x
Highest Risk Band
Net Debt / EBITDA (20%)
Net Cash
Net Cash
Current Ratio (20%)
0.00x
Highest Risk Band
Debt Trend 3yr (15%)
-36%
Rapidly Improving
FCF / Debt Coverage (20%)
Net Cash
No Debt
🤖Model Commentary

PHNX has a financial solvency risk score of 43/100. This represents moderate leverage that warrants monitoring. Interest coverage of -4.0x is adequate but not comfortable. Debt has changed -36% over the last 3 years. The balance sheet appears manageable in normal conditions but could face stress in a downturn. Coverage ratios and free cash flow trends remain important.

💼 Operational Quality

Weight: 30%
55/100

Operational Quality measures bottom-line efficiency, cash generation, capital productivity, and margin consistency — four equally weighted signals of business model resilience.

Net Margin (25%)
-5.1%
Loss Making
FCF Margin (25%)
15.6%
Lower Risk Band
Cash ROA (25%)
1.1%
Weak
Margin Stability (25%)
±13.6pp
Some Variance
🤖Model Commentary

PHNX scores 55/100 for operational quality, indicating elevated operational risk. The company shows healthy free cash flow at 15.6% FCF margin. Key concerns: a negative net margin of -5.1% — the company is loss-making; weak capital efficiency with 1.1% Cash ROA; moderate margin variance of ±13.6pp over 3 years. Overall the business appears viable but not without risk. Margin trends should be monitored over time.

📉 Volatility

Weight: 25%
50/100

Volatility measures price instability, worst-case drawdowns, and sensitivity to broader market moves.

Annualised Volatility (35%)
Max Drawdown (35%)
Beta (30%)
0.85
Market-Like
🤖Model Commentary

PHNX has a volatility risk score of 50/100. This represents moderate-to-elevated volatility — above average but manageable. Investors may experience periodic double-digit declines in this profile.

📊 Size Factor

Weight: 10%
35/100

Size factor captures existential risk. Smaller companies have higher failure rates, less diversification, and greater vulnerability to shocks.

Market Cap
£7.7B
Neutral
Size Category
Mid Cap
Neutral
🤖Model Commentary

PHNX has a market cap of £7.7B (Mid Cap), resulting in a size risk score of 35/100. As a large-cap company, it has comparatively lower size-related risk. Large companies benefit from scale, diversified operations, established brands, and easier access to capital. While not immune to failure, they have resources to navigate challenges and lower statistical failure rates. Size can support operational stability and reduce business fragility, though growth rates may vary. Size-based observations are descriptive and not recommendations.

ℹ️

Educational Tool Only

The risk rating and analysis shown above are based on historical financial data and quantitative metrics, provided for informational and educational purposes only. This is not financial advice and should not be interpreted as a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Always conduct your own research or consult a qualified financial adviser before making investment decisions.

Analyst Forecasts

Forward-looking analyst estimates for PHNX. Forecasts are estimates, not guarantees.

Revenue+15.1% growth
Based on 2 analysts
EPS+34.0% growth
EPS revisions slipping over the past 30 days
Forecast ToneBalanced·Medium agreement
Balanced consensus profile with +15.1% revenue growth and +34.0% EPS growth.
Confidence is medium agreement, coverage sits at 9 analysts, forecast ranges show moderate dispersion, 30-day EPS revisions are softening.
Consensus
+15.1% revenue growth
Consensus target of 758.10p
Confidence
Medium agreement
Based on 9 analysts with moderate dispersion
Watch Item
Revisions are slipping
EPS expectations have been cut over the last 30 days, which weakens the forward setup.

Share Price Forecast

Zoom
Loading chart...
Model Commentary
That view is based on 9 analysts. Medium agreement means the Street is directionally aligned but still leaving room for debate. Analyst targets and forecasts can change quickly after new company or market information.

Yearly Revenue and 2-Year Forecast

Reported revenue for the last 5 years, followed by low, consensus, and high analyst revenue estimates for the next two years. Consensus revenue implies +15.1% YoY growth tight ranges on revenue estimates

Model Commentary
Revenue is projected to move from 21.4B last year to 5.9B in 2025E and 6.8B in 2026E. That implies -72.6% into 2025E and +15.1% into 2026E on the top line. The 2026E range of 6.4B to 7.2B suggests tight ranges on revenue expectations. Revenue misses can lead to EPS estimate revisions and changes in valuation assumptions. Forecast ranges reflect uncertainty and should be read alongside risk metrics.

2-Year EPS Estimates

Low, consensus, and high analyst EPS estimates for the next two fiscal years. Consensus EPS implies +34.0% YoY growth moderate dispersion on EPS estimates

Model Commentary
Analysts are currently looking for 52.21p in 2025E and 69.97p in 2026E. The outer-year range runs from 62.14p to 78.23p, which counts as moderate dispersion. Consensus currently models +34.0% EPS growth over the next period. EPS estimates are subject to revision and do not guarantee future results.